BioCardia, Inc. 6JU.F Stock
BioCardia, Inc. Price Chart
BioCardia, Inc. 6JU.F Financial and Trading Overview
| BioCardia, Inc. stock price | 0.34 EUR |
| Previous Close | 2.04 EUR |
| Open | 2.06 EUR |
| Bid | 2.06 EUR x N/A |
| Ask | 2.12 EUR x N/A |
| Day's Range | 2.06 - 2.06 EUR |
| 52 Week Range | 1.3 - 2.4 EUR |
| Volume | 150 EUR |
| Avg. Volume | 2 EUR |
| Market Cap | 41.65M EUR |
| Beta (5Y Monthly) | 1.019718 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.43 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.17 EUR |
6JU.F Valuation Measures
| Enterprise Value | 37.94M EUR |
| Trailing P/E | N/A |
| Forward P/E | -1.9807693 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 30.71633 |
| Price/Book (mrq) | 21.914894 |
| Enterprise Value/Revenue | 27.983 |
| Enterprise Value/EBITDA | -3.163 |
Trading Information
BioCardia, Inc. Stock Price History
| Beta (5Y Monthly) | 1.019718 |
| 52-Week Change | 59.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.4 EUR |
| 52 Week Low | 1.3 EUR |
| 50-Day Moving Average | 1.77 EUR |
| 200-Day Moving Average | 1.9 EUR |
6JU.F Share Statistics
| Avg. Volume (3 month) | 2 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 20.22M |
| Float | 10.55M |
| Short Ratio | N/A |
| % Held by Insiders | 29.44% |
| % Held by Institutions | 15.95% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -891.14% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -75.64% |
| Return on Equity (ttm) | -260.71% |
Income Statement
| Revenue (ttm) | 1.36M EUR |
| Revenue Per Share (ttm) | 0.07 EUR |
| Quarterly Revenue Growth (yoy) | 6.70% |
| Gross Profit (ttm) | -7482000 EUR |
| EBITDA | -11996000 EUR |
| Net Income Avi to Common (ttm) | -12083000 EUR |
| Diluted EPS (ttm) | -0.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.86M EUR |
| Total Cash Per Share (mrq) | 0.24 EUR |
| Total Debt (mrq) | 1.56M EUR |
| Total Debt/Equity (mrq) | 81.84 EUR |
| Current Ratio (mrq) | 1.322 |
| Book Value Per Share (mrq) | 0.094 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10208000 EUR |
| Levered Free Cash Flow (ttm) | -6033500 EUR |
Profile of BioCardia, Inc.
| Country | Germany |
| State | CA |
| City | Sunnyvale |
| Address | 320 Soquel Way |
| ZIP | 94085 |
| Phone | 650 226 0120 |
| Website | https://www.biocardia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 30 |
BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
Q&A For BioCardia, Inc. Stock
What is a current 6JU.F stock price?
BioCardia, Inc. 6JU.F stock price today per share is 0.34 EUR.
How to purchase BioCardia, Inc. stock?
You can buy 6JU.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioCardia, Inc.?
The stock symbol or ticker of BioCardia, Inc. is 6JU.F.
Which industry does the BioCardia, Inc. company belong to?
The BioCardia, Inc. industry is Biotechnology.
How many shares does BioCardia, Inc. have in circulation?
The max supply of BioCardia, Inc. shares is 29.16M.
What is BioCardia, Inc. Price to Earnings Ratio (PE Ratio)?
BioCardia, Inc. PE Ratio is now.
What was BioCardia, Inc. earnings per share over the trailing 12 months (TTM)?
BioCardia, Inc. EPS is -0.43 EUR over the trailing 12 months.
Which sector does the BioCardia, Inc. company belong to?
The BioCardia, Inc. sector is Healthcare.